112 related articles for article (PubMed ID: 8847059)
1. A long-term surviving patient with hepatocellular carcinoma including lymphocytes infiltration--a clinicopathological study.
Shirabe K; Matsumata T; Maeda T; Sadanaga N; Kuwano H; Sugimachi K
Hepatogastroenterology; 1995; 42(6):996-1001. PubMed ID: 8847059
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.
Wada Y; Nakashima O; Kutami R; Yamamoto O; Kojiro M
Hepatology; 1998 Feb; 27(2):407-14. PubMed ID: 9462638
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
[TBL] [Abstract][Full Text] [Related]
4. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma.
Kawata A; Une Y; Hosokawa M; Uchino J; Kobayashi H
Jpn J Clin Oncol; 1992 Aug; 22(4):256-63. PubMed ID: 1331571
[TBL] [Abstract][Full Text] [Related]
6. Histological analysis of hepatocellular carcinoma treated by intraarterial combined immunochemotherapy.
Oka M; Hazama S; Suzuki M; Ogura Y; Kobayashi N; Suzuki T
Hepatogastroenterology; 1995; 42(5):561-6. PubMed ID: 8751216
[TBL] [Abstract][Full Text] [Related]
7. [Increase in peripheral and liver infiltrating regulatory T cells favors development of primary hepatocellular carcinoma].
Wang SY; Fu JL; Lv JY; Chen LM; Lv S; Wang FS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):668-70. PubMed ID: 21651872
[TBL] [Abstract][Full Text] [Related]
8. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation.
Unitt E; Marshall A; Gelson W; Rushbrook SM; Davies S; Vowler SL; Morris LS; Coleman N; Alexander GJ
J Hepatol; 2006 Aug; 45(2):246-53. PubMed ID: 16580084
[TBL] [Abstract][Full Text] [Related]
9. [Infiltration of dendritic cells and lymphocytes in hepatocellular carcinoma tissue].
Yin X; Lu M; Liang L; Lai Y; Huang J; Li Z
Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):336-43. PubMed ID: 12133336
[TBL] [Abstract][Full Text] [Related]
10. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between dendritic cells and memory T lymphocytes in tumor site and prognosis of hepatocellular carcinoma].
Cai XY; Qiu SJ; Wu ZQ; Ye SL; Fan J; Zhou J; Tang ZY
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):671-5. PubMed ID: 15932729
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significances of tumor-infiltrating S-100 positive dendritic cells and lymphocytes in patients with hepatocellular carcinoma.
Yin XY; Lu MD; Lai YR; Liang LJ; Huang JF
Hepatogastroenterology; 2003; 50(53):1281-4. PubMed ID: 14571719
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma.
Chen CH; Lee HS; Huang GT; Yang PM; Yu WY; Cheng KC; Lee PH; Jeng YM; Chen DS; Sheu JC
Hepatogastroenterology; 2007; 54(77):1529-33. PubMed ID: 17708291
[TBL] [Abstract][Full Text] [Related]
14. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma with massive lymphoid infiltration: a regressing phenomenon?
Park HS; Jang KY; Kim YK; Cho BH; Moon WS
Pathol Res Pract; 2009; 205(9):648-52. PubMed ID: 19217218
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M
Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188
[TBL] [Abstract][Full Text] [Related]
17. Fas antigen expression in hepatocellular carcinoma tissues.
Ito Y; Takeda T; Umeshita K; Sakon M; Wakasa K; Matsuura N; Monden M
Oncol Rep; 1998; 5(1):41-4. PubMed ID: 9458289
[TBL] [Abstract][Full Text] [Related]
18. [Hepatocellular carcinoma with lymphoid stroma: report of two cases].
Choi HJ; Choi JH
Korean J Hepatol; 2008 Sep; 14(3):394-8. PubMed ID: 18815463
[TBL] [Abstract][Full Text] [Related]
19. Expression of transforming growth factor-beta 1 in hepatocellular carcinoma in comparison with the non-tumor tissue.
Idobe Y; Murawaki Y; Kitamura Y; Kawasaki H
Hepatogastroenterology; 2003; 50(49):54-9. PubMed ID: 12629989
[TBL] [Abstract][Full Text] [Related]
20. Long-term surviving patients with hepatocellular carcinoma comprised of dense collagenous stroma.
Sonoda T; Shirabe K; Kanematsu T; Takenaka K; Sugimachi K
Am J Gastroenterol; 1989 Sep; 84(9):1087-91. PubMed ID: 2549782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
